Literature DB >> 7491785

Intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase subunits during infection of cultured cells.

J Conner1, J Murray, A Cross, J B Clements, H S Marsden.   

Abstract

We have analysed the intracellular localisation of herpes simplex virus type 1 ribonucleotide reductase during infection of cultured cells by indirect immunofluorescence using polyclonal and monoclonal antibodies specific for the R1 and R2 subunits. Three different viruses were used to infect cells, wild-type strain 17+ and two temperature-sensitive mutants, ts 1222, which produces R1 only, and ts 1207, which expresses a normal R2 and an altered R1 that fails to interact with R2 at the nonpermissive temperature because of an amino acid substitution in R1. R1 was detected 2 hr postinfection with all three viruses and remained evenly distributed throughout the cytoplasm. R2 was not observed until 4 hr postinfection and, in contrast to the even distribution of R1, was localised in discrete cytoplasmic foci close to the nucleus. In double-labelling experiments both R1 and R2 were found in these foci where they presumably associate to form the active enzyme. As expected R2 was not detectable in cells infected with ts 1222. In ts 1207-infected cells it formed wild-type-like foci, indicating that interaction with R1 is not required for R2 focus formation. R1 was present in a twofold excess over R2 in wild-type-infected cells. We suggest that the uncomplexed R1 could perform a role associated with the protein kinase present in the N-terminal domain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491785     DOI: 10.1006/viro.1995.0033

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Identification of RNR4, encoding a second essential small subunit of ribonucleotide reductase in Saccharomyces cerevisiae.

Authors:  M Huang; S J Elledge
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Human neuron-committed teratocarcinoma NT2 cell line has abnormal ND10 structures and is poorly infected by herpes simplex virus type 1.

Authors:  W L Hsu; R D Everett
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.

Authors:  C C Smith; J Nelson; L Aurelian; M Gober; B B Goswami
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.

Authors:  Y Sun; J Conner
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

5.  Phenotype of a herpes simplex virus type 1 mutant that fails to express immediate-early regulatory protein ICP0.

Authors:  Roger D Everett; Chris Boutell; Anne Orr
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Herpes simplex virus type 1 blocks the apoptotic host cell defense mechanisms that target Bcl-2 and manipulates activation of p38 mitogen-activated protein kinase to improve viral replication.

Authors:  G Zachos; M Koffa; C M Preston; J B Clements; J Conner
Journal:  J Virol       Date:  2001-03       Impact factor: 6.549

Review 7.  Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.

Authors:  Chad R Irwin; Mary M Hitt; David H Evans
Journal:  Front Oncol       Date:  2017-09-26       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.